2010
Psychotropic Medications in Autism: Practical Considerations for Parents
Williamson ED, Martin A. Psychotropic Medications in Autism: Practical Considerations for Parents. Journal Of Autism And Developmental Disorders 2010, 42: 1249-1255. PMID: 21170674, DOI: 10.1007/s10803-010-1144-2.Peer-Reviewed Original Research
2004
Electrocardiographic safety profile and monitoring guidelines in pediatric psychopharmacology
Blair J, Taggart B, Martin A. Electrocardiographic safety profile and monitoring guidelines in pediatric psychopharmacology. Journal Of Neural Transmission 2004, 111: 791-815. PMID: 15205999, DOI: 10.1007/s00702-004-0153-8.Peer-Reviewed Original ResearchMeSH KeywordsElectrocardiographyHumansLong QT SyndromePractice Guidelines as TopicPsychopharmacologyPsychotropic DrugsConceptsPediatric psychopharmacologyQTc prolongationQTc intervalNumber of medicationsTricyclic antidepressant desipramineAdult patientsYounger patientsElectrocardiographic monitoringAlpha agonistsSafety profileDeadly arrhythmiasAntidepressant desipramineSudden deathAdverse effectsMost reportsPatientsPsychopharmacologyProlongationCurrent knowledgeChildrenReportGuidelinesAntipsychoticsMedicationsTorsades
2003
Trends in Psychotropic Medication Costs for Children and Adolescents, 1997-2000
Martin A, Leslie D. Trends in Psychotropic Medication Costs for Children and Adolescents, 1997-2000. JAMA Pediatrics 2003, 157: 997-1004. PMID: 14557161, DOI: 10.1001/archpedi.157.10.997.Peer-Reviewed Original ResearchConceptsCostly medicationsSelective serotonin reuptake inhibitorsPsychotropic medication costsPsychotropic medication utilizationSerotonin reuptake inhibitorsWarrants further studyMental health outpatientsMedication utilizationAtypical antidepressantsAtypical antipsychoticsPharmacy claimsReuptake inhibitorsMedication costsPsychotropic drugsDrug categoriesMedicationsNational databaseDrugsOverall useFurther studiesChildrenPrescription pricesAntipsychoticsAntidepressantsOutpatientsPsychiatric Inpatient, Outpatient, and Medication Utilization and Costs Among Privately Insured Youths, 19972000
Martin A, Leslie D. Psychiatric Inpatient, Outpatient, and Medication Utilization and Costs Among Privately Insured Youths, 19972000. American Journal Of Psychiatry 2003, 160: 757-764. PMID: 12668366, DOI: 10.1176/appi.ajp.160.4.757.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdolescent Health ServicesAge FactorsAmbulatory CareChildDrug CostsDrug UtilizationFemaleHealth Benefit Plans, EmployeeHealth Care CostsHealth Care SurveysHospitalizationHumansInsurance, PsychiatricLength of StayMaleManaged Care ProgramsMental DisordersMental Health ServicesPsychotropic DrugsUnited StatesUtilization ReviewConceptsOutpatient visitsPsychotropic medicationsProportion of youthOutpatient mental health servicesAnxiety disordersMedication-related costsOutpatient treatment modalityUse of inpatientTreatment of depressionInpatient psychiatric admissionAnalysis of inpatientMental health servicesAge 17 yearsAnnual utilization ratesMedication utilizationPharmacy claimsOutpatient costsTreatment modalitiesPsychiatric admissionsAnnual inpatientAdjustment disorderInpatient daysInpatientsHealth servicesPsychiatric inpatients
2000
The use of psychotropic medications in young children: the facts, the controversy, and the practice.
Stubbe DE, Martin A. The use of psychotropic medications in young children: the facts, the controversy, and the practice. Connecticut Medicine 2000, 64: 329-33. PMID: 10909194.Peer-Reviewed Original Research